ContextLogic Inc. - Class A Common Stock (LOGC)

Sentiment on Stocktwits ended ‘neutral’ on Wednesday compared to ‘bearish’ a day ago.

LogicBio Therapeutics's (NASDAQ:LOGC) short percent of float has fallen 62.5% since its last report. The company recently reported that it has 29 thousand shares sold short, which is 0.12% of all regular shares that are available for trading.

Under the deal, BC Partners planned to buy up to $150 million of convertible preferred units, a newly-formed Delaware limited liability company and a wholly-owned subsidiary of the company.

BC Partners invests $150M in ContextLogic, providing access to $300M in capital. New board members to maximize shareholder value and drive growth.

LOGC stock results show that ContextLogic missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 270 points on Monday.

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.

Gainers

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.

U.S. stocks extended gains midway through trading, with the Dow Jones gaining more than 600 points on Monday.

Investors are still interested in short squeeze stocks lately and we've got them covered with the ones to watch this week!

Blue Apron (APRN) stock is sliding lower on Monday as investors react to its CFO leaving the company and plans for a stock sale.

LogicBio (LOGC) stock is seeing massive gains on Monday following news that AstraZeneca (AZN) subsidiary Alexion is acquiring the company.

Gainers LogicBio Therapeutics (NASDAQ:LOGC) shares moved upwards by 641.3% to $2.02 during Monday's pre-market session. The company's market cap stands at $66.5 million.

LogicBio Therapeutics Inc (NASDAQ: LOGC) shares are trading higher Monday after the company announced it will be acquired by AstraZeneca PLC (NASDAQ: AZN) subsidiary Alexion for $2.07 per share. 

Gainers Reshape Lifesciences (NASDAQ:RSLS) stock increased by 10.1% to $0.39 during Monday's after-market session. The company's market cap stands at $1.3 million.

U.S. stocks traded higher toward the end of trading, with the Dow Jones around 170 points on Monday.

 

Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.

U.S. stocks traded turned higher midway through trading, with the Dow Jones gaining more than 100 points on Monday.

Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New Energy effective as of August 10, 2022.